Jayne B. Hart - 09 Jun 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief People Officer
Signature
By: Nathan A. Smith For: Jayne B. Hart
Issuer symbol
MYGN
Transactions as of
09 Jun 2022
Transactions value $
$15,375
Form type
4
Filing time
10 Jun 2022, 16:40:41 UTC
Previous filing
25 Mar 2022
Next filing
26 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $15.4K +1.04K +0.57% $14.84 183K 09 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Myriad Genetics, Inc. 2012 Amended and Restated Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).